An Exclusive AI Partnership Boosts South Korea's Tech Landscape
OpenAI and SK Telecom Join Forces: Elevating AI in South Korea with Premium ChatGPT
OpenAI and South Korea's leading telecom giant SK Telecom (SKT) have announced an exciting partnership to bring a premium version of ChatGPT to South Korean users. This strategic collaboration makes SKT the exclusive partner for distributing ChatGPT Plus in Korea, supporting OpenAI's goal to expand its footprint in the Asian market. With a special promotion offering two free months of ChatGPT Plus on a one‑month paid plan, this partnership aims to accelerate AI adoption among Korean consumers. This move is part of OpenAI’s larger initiative to fortify ties in South Korea, where it has recently established an office and is exploring further collaborations with local companies and academia.
Introduction to OpenAI and SK Telecom Partnership
Details of ChatGPT Plus Offer in South Korea
Significance of SK Telecom as OpenAI's Partner
OpenAI's Expansion Plans in South Korea
Collaborations with Korean Companies and Academia
Public Reactions to the Partnership
Future Economic and Social Implications
Strategic and Political Considerations
Expert and Industry Perspectives
Conclusion
Related News
Apr 24, 2026
DeepSeek's Open-Source A.I. Surge: Game Changer in Global Competition
DeepSeek's release of its open-source V4 model propels its position in the A.I. race, challenging American giants with cost-efficiency and openness. For global builders, this marks a new era of accessible, powerful tools for software development.
Apr 24, 2026
White House Hits Back at China's Alleged AI Tech Theft
A White House memo has accused Chinese firms of large-scale AI technology theft. Michael Kratsios warns of systematic tactics undermining US R&D. No specific punitive measures detailed yet.
Apr 24, 2026
OpenAI Debuts ChatGPT for Clinicians with Free CME Credits and Cited Medical Insights
OpenAI rolls out ChatGPT for Clinicians, offering U.S. healthcare providers a free tool to access cited medical sources and earn CME credits. Built on GPT-5.4, this tool aids doctors, nurse practitioners, and other licensed clinicians in streamlining research and clinical documentation. The platform emphasizes professional support without replacing clinical judgment.